4//SEC Filing
Murphy Sean 4
Accession 0001415889-25-002291
CIK 0001826667other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 6:13 PM ET
Size
12.7 KB
Accession
0001415889-25-002291
Insider Transaction Report
Form 4
Murphy Sean
DirectorChief Manuf, Strategy&Bus Dev.
Transactions
- Purchase
Common Stock
2025-01-27$5.31/sh+15,000$79,650→ 182,732 total(indirect: By Sean E Murphy TTEE U/A 2/4/2004) - Purchase
Common Stock
2025-01-28$5.17/sh+15,000$77,550→ 197,732 total(indirect: By Sean E Murphy TTEE U/A 2/4/2004) - Award
Common Stock
2025-01-27+12,500→ 63,288 total - Award
Employee Stock Option (right to buy)
2025-01-27+75,000→ 75,000 totalExercise: $5.30Exp: 2035-01-26→ Common Stock (75,000 underlying)
Holdings
- 357,535(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.09 to $5.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.94 to $5.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The Reporting Person's spouse has voting and investment discretion with respect to the shares held directly by Murphy Family Trust 2012 and thus the Reporting Person may be deemed to have beneficial ownership of the shares held directly by Murphy Family Trust 2012.
- [F5]One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service through each such vesting date.
Documents
Issuer
TriSalus Life Sciences, Inc.
CIK 0001826667
Entity typeother
Related Parties
1- filerCIK 0001685042
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 6:13 PM ET
- Size
- 12.7 KB